カテゴリ： MarketLine, イギリス, 企業調査

Vodafone Group Plc：戦略・SWOT・企業財務分析

◆英語タイトル：Vodafone Group Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015252
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：63
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：通信・IT
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Vodafone Group Plc – Strategy, SWOT and Corporate Finance Report
Summary

Vodafone Group Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vodafone Group Public Limited Company (Vodafone or “the group”) is a telecommunications company providing a range of services, including voice, messaging, data and fixed broadband. The group operates in Europe, and Africa, Middle East, and Asia Pacific (AMAP). It is headquartered in Berkshire, the UK and employed 111,684 people as of March 31, 2016.

Scope

- Detailed information on Vodafone Group Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vodafone Group Plc in the form of a SWOT analysis
- An in-depth view of the business model of Vodafone Group Plc including a breakdown and examination of key business segments
- Intelligence on Vodafone Group Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vodafone Group Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vodafone Group Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vodafone Group Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vodafone Group Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Vodafone Group Plc: Company Overview
Vodafone Group Plc: Overview and Key Facts
Vodafone Group Plc: Overview
Vodafone Group Plc: Key Facts
Vodafone Group Plc: Key Employees
Vodafone Group Plc: Key Employee Biographies
Vodafone Group Plc: Major Products and Services
Vodafone Group Plc: Company History
Vodafone Group Plc: Management Statement
Vodafone Group Plc: Locations and Subsidiaries
Vodafone Group Plc: Key Competitors
Vodafone Group Plc: Company Analysis
Vodafone Group Plc: Business Description
Vodafone Group Plc: SWOT Analysis
Vodafone Group Plc: SWOT Overview
Vodafone Group Plc: Strengths
Vodafone Group Plc: Weaknesses
Vodafone Group Plc: Opportunities
Vodafone Group Plc: Threats
Vodafone Group Plc: Corporate Financial Deals Activity
Vodafone Group Plc: Financial Deals Overview
Vodafone Group Plc: Targets and Partners
Vodafone Group Plc: Top Deals 2013 – 2017YTD*
Vodafone Group Plc: Advisors
Vodafone Group Plc: Top Legal Advisors
Vodafone Group Plc: Top Financial Advisors
Vodafone Group Plc: Mergers and Acquisitions
Vodafone Group Plc: Capital Raising
Vodafone Group Plc: Partnership
Vodafone Group Plc: Divestments
Vodafone Group Plc: Recent Developments
Vodafone Group Plc: News and Events Summary
Vodafone Group Plc: Contracts
Vodafone Group Plc: Financial Deals
Vodafone Group Plc: IT Spending Announcements
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Vodafone Group Plc: Key Facts
Table 2: Vodafone Group Plc: Key Employees
Table 3: Vodafone Group Plc: Locations and Subsidiaries
Table 4: Vodafone Group Plc: Key Competitors
Table 5: Vodafone Group Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vodafone Group Plc: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Vodafone Group Plc: M&A Average Deal Size - Value (US$m)
Table 8: Vodafone Group Plc: Targets and Partners
Table 9: Vodafone Group Plc: Top Deals 2013 - 2017YTD*
Table 10: Vodafone Group Plc: Legal Advisor Ranking by Value (US$m)
Table 11: Vodafone Group Plc: Financial Advisor Ranking by Value (US$m)
Table 12: Vodafone Group Plc: M&A Volume and Value Trend (2013 - YTD*2017)
Table 13: Vodafone Group Plc: M&A Activity by Geography (2013 - YTD*2017)
Table 14: Vodafone Group Plc: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 15: Vodafone Group Plc: Capital Raising by Deal Type (2013 - YTD*2017)
Table 16: Vodafone Group Plc: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 17: Vodafone Group Plc: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 18: Vodafone Group Plc: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 19: Vodafone Group Plc: Divestments by Geography (2013 - YTD*2017)
Table 20: Vodafone Group Plc: News and Events Summary
Table 21: Vodafone Group Plc: Contracts
Table 22: Vodafone Group Plc: Financial Deals
Table 23: Vodafone Group Plc: IT Spending Announcements

★海外企業調査レポート[Vodafone Group Plc：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Storm Therapeutics Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Storm Therapeutics Ltd (Storm Therapeutics) a spin-out of University of Cambridge is focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer and other diseases. The company is engaged in modulating RNA modifying enzymes and is developing a unique …
  • Biogen Inc (BIIB)：企業の財務・戦略的SWOT分析
    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Imperial College London-製薬・医療分野：企業M&A・提携分析
    Summary Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical tr …
  • Greentech Energy Systems AS (GES)-エネルギー分野：企業M&A・提携分析
    Summary Greentech Energy Systems AS (Greentech) is an energy company which operates renewable energy plants. It generates electricity from wind and solar sources. Through long-term power purchase agreements, the company sells electricity. Greentech expands its asset portfolio through inorganic growt …
  • Nacional Financiera S.N.C.：企業の戦略・SWOT・財務情報
    Nacional Financiera S.N.C. - Strategy, SWOT and Corporate Finance Report Summary Nacional Financiera S.N.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • MedX Health Corp (MDX)：医療機器：M&Aディール及び事業提携情報
    Summary MedX Health Corp (MedX) is a medical device company that designs, manufactures and distributes phototherapeutic devices. The company’s phototherapy products include rehab laser console system, acupuncture portable laser console system, rehab portable laser, oralase portable laser probe, and …
  • Novus Therapeutics Inc (NVUS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Novus Therapeutics Inc (Tokai Pharma), formerly Tokai Pharmaceuticals Inc is a pharmaceutical company that develops products for ear, nose and throat. The company’s lead products is a nasally-administer, combination drug product and eustachian tube dysfunction, among others. Its galeterone i …
  • China Longyuan Power Group Corp Ltd (916)：企業の財務・戦略的SWOT分析
    China Longyuan Power Group Corp Ltd (916) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • The Tokyo Electric Power Company Holdings., Incorporated：企業の戦略・SWOT・財務分析
    The Tokyo Electric Power Company Holdings., Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Electric Power Company Holdings., Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the comp …
  • American Builders & Contractors Supply Co Inc：企業の戦略・SWOT・財務情報
    American Builders & Contractors Supply Co Inc - Strategy, SWOT and Corporate Finance Report Summary American Builders & Contractors Supply Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • John Menzies Plc：企業の戦略・SWOT・財務分析
    John Menzies Plc - Strategy, SWOT and Corporate Finance Report Summary John Menzies Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Lisega SE：企業の戦略的SWOT分析
    Lisega SE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Shimadzu Corp (7701)：企業の財務・戦略的SWOT分析
    Shimadzu Corp (7701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Varian Medical Systems Inc (VAR)：医療機器：M&Aディール及び事業提携情報
    Summary Varian Medical Systems Inc (VMS) designs, manufactures and sells medical devices and software for the treatment of cancer and other medical conditions through radiotherapy, proton therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. The company’s major produ …
  • SELLAS Life Sciences Group Inc (SLS)：医療機器：M&Aディール及び事業提携情報
    Summary SELLAS Life Sciences Group Inc (SELLAS), formerly Galena Biopharma Inc, is a clinical-stage biopharmaceutical company that develops novel cancer immunotherapeutics for a broad range of cancer indications. Its lead product candidate, galinpepimut-S, is a Wilms Tumor 1 (WT1) protein-targeting …
  • Ontario Power Generation Inc.：企業の戦略・SWOT・財務分析
    Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report Summary Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Teva Pharmaceuticals USA Inc-製薬・医療分野：企業M&A・提携分析
    Summary Teva Pharmaceuticals USA Inc (Teva Pharmaceuticals), formerly Lemmon Pharmacal Company, a subsidiary of Teva Pharmaceutical Industries Ltd, is a developer and manufacturer of pharmaceutical ingredients. The company’s products include antiulcer agents and acid suppressants, antiviral capsules …
  • Baoviet Holdings
    Baoviet Holdings - Strategy, SWOT and Corporate Finance Report Summary Baoviet Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • First Republic Bank：企業の戦略・SWOT・財務分析
    First Republic Bank - Strategy, SWOT and Corporate Finance Report Summary First Republic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sempra Energy (SRE)：企業の財務・戦略的SWOT分析
    Sempra Energy (SRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆